Related Experiment Videos
[Clinical and pharmacokinetic study of amikacin in septicemia complicating major burns]
La Nouvelle Presse Medicale
|October 31, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Severely reduced antioxidant and impaired mitochondrial biomarkers could be linked to post-tuberculosis lung disease in a cohort from South Africa.
African journal of thoracic and critical care medicine·2026
Prevalence of alcohol use, associated risk factors, and the impact on the HIV care cascade among adolescent girls and young women in South Africa: Findings from the HERStory Study.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Depression and post-traumatic stress symptoms two years post-rape and the role of early counselling: Rape Impact Cohort Evaluation (RICE) study.
European journal of psychotraumatology·2023
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants.
Pulmonology·2023
[Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
La Nouvelle presse medicale·1982
[Plasmapheresis in autoimmune syndromes. Indications. Results].
La Nouvelle presse medicale·1982
[Relation between monoclonal gammopathy and hepatobiliary disease].
La Nouvelle presse medicale·1982
Two decades of prescription opioid-related cardiovascular safety signals: a FAERS-based pharmacovigilance study using machine learning.
Frontiers in drug safety and regulation·2026
Mitochondrial protein import stress in Parkinson's disease: the TOM/TIM-PINK1/Parkin-DELE1/HRI axis linking mitochondrial proteostasis to neuronal death.
Frontiers in cell and developmental biology·2026
Association of Gallstone Disease and Cholecystectomy With Duodenal Polyps and Barrett's Oesophagus.
Alimentary pharmacology & therapeutics·2026
Dopamine Homeostasis, Cognitive Testing, and Precision Pain Management: A Narrative Review of Reward Circuitry, Opioid Risk, and Personalized Recovery Metrics.
Current pharmaceutical biotechnology·2026